Dr. Samuel Lee is a highly accomplished physician executive and innovator with a unique blend of clinical expertise (MD) and strategic business acumen (MBA). With nearly two decades of experience spanning clinical practice, healthcare management, and biotechnology leadership, Dr. Lee is passionate about leveraging technology and data-driven strategies to improve patient outcomes and transform healthcare delivery. He has a strong track record in leading cross-functional teams, developing and launching new medical products, and navigating complex regulatory landscapes. His focus areas include digital health, precision medicine, and value-based care initiatives. Dr. Lee is recognized for his visionary thinking, ethical leadership, and commitment to bridging the gap between medical innovation and practical application.
Samuel Lee's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Spearheaded the development and commercialization of an innovative AI-driven diagnostic platform for early cancer detection, resulting in a 25% improvement in diagnostic accuracy in clinical trials and subsequent FDA approval.
Played a key role in the strategic restructuring of a regional hospital network, implementing new operational efficiencies and care models that led to a 15% reduction in operational costs while improving patient satisfaction scores by 10%.
As Chief Medical Officer for a biotech startup, successfully led the clinical strategy and presentations that secured $50 million in Series B funding for advancing novel therapeutic research.
Authored and co-authored over 20 peer-reviewed publications and book chapters on topics related to digital health, healthcare economics, and the application of AI in medicine, frequently presenting at international conferences.
Stanford University Graduate School of Business
The Johns Hopkins University
University of Cincinnati
Miami University
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company dedicated to developing novel medicines for cancers with high unmet medical needs. Their primary focus is on advancing a pipeline of Caveolin-1 (CAV1) targeted therapies designed to overcome treatment resistance and improve patient outcomes in various challenging cancer indications. The company leverages deep expertise in cancer biology and drug development to bring innovative treatments from discovery to clinical application.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.